Cargando…

Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma

BACKGROUND: Dysregulation of chromatin regulators (CRs) can perturb the tumor immune microenvironment, but the underlying mechanism remains unclear. We focused on uterine corpus endometrial carcinoma (UCEC) and used gene expression data from TCGA-UCEC to investigate this mechanism. METHODS: We used...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qihui, Tian, Ruotong, Liu, Jiaxin, Ou, Chunlin, Li, Yimin, Fu, Xiaodan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022674/
https://www.ncbi.nlm.nih.gov/pubmed/36936912
http://dx.doi.org/10.3389/fimmu.2023.1139126
_version_ 1784908771891347456
author Wu, Qihui
Tian, Ruotong
Liu, Jiaxin
Ou, Chunlin
Li, Yimin
Fu, Xiaodan
author_facet Wu, Qihui
Tian, Ruotong
Liu, Jiaxin
Ou, Chunlin
Li, Yimin
Fu, Xiaodan
author_sort Wu, Qihui
collection PubMed
description BACKGROUND: Dysregulation of chromatin regulators (CRs) can perturb the tumor immune microenvironment, but the underlying mechanism remains unclear. We focused on uterine corpus endometrial carcinoma (UCEC) and used gene expression data from TCGA-UCEC to investigate this mechanism. METHODS: We used weighted gene co-expression network analysis (WGCNA) and consensus clustering algorithm to classify UCEC patients into Cluster_L and Cluster_H. TME-associated CRs were identified using WGCNA and differential gene expression analysis. A CR risk score (CRRS) was constructed using univariate Cox and LASSO-Cox regression analyses. A nomogram was developed based on CRRS and clinicopathologic factors to predict patients' prognosis. RESULTS: Lower CRRS was associated with lower grade, more benign molecular subtypes, and improved survival. Patients with low CRRS showed abundant immune infiltration, a higher mutation burden, fewer CNVs, and better response to immunotherapy. Moreover, low CRRS patients were more sensitive to 24 chemotherapeutic agents. CONCLUSION: A comprehensive assessment of CRRS could identify immune activation and improve the efficacy of UCEC treatments.
format Online
Article
Text
id pubmed-10022674
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100226742023-03-18 Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma Wu, Qihui Tian, Ruotong Liu, Jiaxin Ou, Chunlin Li, Yimin Fu, Xiaodan Front Immunol Immunology BACKGROUND: Dysregulation of chromatin regulators (CRs) can perturb the tumor immune microenvironment, but the underlying mechanism remains unclear. We focused on uterine corpus endometrial carcinoma (UCEC) and used gene expression data from TCGA-UCEC to investigate this mechanism. METHODS: We used weighted gene co-expression network analysis (WGCNA) and consensus clustering algorithm to classify UCEC patients into Cluster_L and Cluster_H. TME-associated CRs were identified using WGCNA and differential gene expression analysis. A CR risk score (CRRS) was constructed using univariate Cox and LASSO-Cox regression analyses. A nomogram was developed based on CRRS and clinicopathologic factors to predict patients' prognosis. RESULTS: Lower CRRS was associated with lower grade, more benign molecular subtypes, and improved survival. Patients with low CRRS showed abundant immune infiltration, a higher mutation burden, fewer CNVs, and better response to immunotherapy. Moreover, low CRRS patients were more sensitive to 24 chemotherapeutic agents. CONCLUSION: A comprehensive assessment of CRRS could identify immune activation and improve the efficacy of UCEC treatments. Frontiers Media S.A. 2023-03-03 /pmc/articles/PMC10022674/ /pubmed/36936912 http://dx.doi.org/10.3389/fimmu.2023.1139126 Text en Copyright © 2023 Wu, Tian, Liu, Ou, Li and Fu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wu, Qihui
Tian, Ruotong
Liu, Jiaxin
Ou, Chunlin
Li, Yimin
Fu, Xiaodan
Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
title Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
title_full Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
title_fullStr Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
title_full_unstemmed Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
title_short Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
title_sort deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022674/
https://www.ncbi.nlm.nih.gov/pubmed/36936912
http://dx.doi.org/10.3389/fimmu.2023.1139126
work_keys_str_mv AT wuqihui decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma
AT tianruotong decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma
AT liujiaxin decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma
AT ouchunlin decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma
AT liyimin decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma
AT fuxiaodan decipheringcomprehensivefeaturesoftumormicroenvironmentcontrolledbychromatinregulatorstopredictprognosisandguidetherapiesinuterinecorpusendometrialcarcinoma